Akiko Inujima

Dr. Akiko Inujima

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JKJi-Ye Kee
Ji-Ye Kee
AIAya Ito
Aya Ito
SHShozo Hojo
Shozo Hojo
IHIsaya Hashimoto
Isaya Hashimoto
YIYoshiko Igarashi
Yoshiko Igarashi
KKKeiichi Koizumi
Keiichi Koizumi
Inhibition of metastasis through upregulation of immune surveillance is a major purpose of chemokine gene therapy. In this study, we focused on a membrane-bound chemokine CXCL16, which has shown a correlation with a good prognosis for colorectal cancer (CRC) patients. We generated a CXCL16-expressing metastatic CRC cell line and identified changes in TNF and apoptosis-related factors. To investigate the effect of CXCL16 on colorectal liver metastasis, we injected SL4-Cont and SL4-CXCL16 cells into intraportal vein in C57BL/6 mice and evaluated the metastasis. Moreover, we analyzed metastatic liver tissues using flow cytometry whether CXCL16 expression regulates the infiltration of M1 macrophages. CXCL16 expression enhanced TNF-α-induced apoptosis through activation of PARP and the caspase-3-mediated apoptotic pathway and through inactivation of the NF-κB-mediated survival pathway. Several genes were changed by CXCL16 expression, but we focused on IRF8, which is a regulator of apoptosis and the metastatic phenotype. We confirmed CXCL16 expression in SL4-CXCL16 cells and the correlation between CXCL16 and IRF8. Silencing of IRF8 significantly decreased TNF-α-induced apoptosis. Liver metastasis of SL4-CXCL16 cells was also inhibited by TNF-α-induced apoptosis through the induction of M1 macrophages, which released TNF-α. Our findings suggest that the accumulation of M1 macrophages and the enhancement of apoptosis by CXCL16 might be an effective dual approach against CRC liver metastasis. Collectively, this study revealed that CXCL16 regulates immune surveillance and cell signaling. Therefore, we provide the first evidence of CXCL16 serving as an intracellular signaling molecule.

1 December 2018 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
HIHirofumi Iitsuka
Hirofumi Iitsuka
KKKeiichi Koizumi
Keiichi Koizumi
AIAkiko Inujima
Akiko Inujima
MSMikiko Suzaki
Mikiko Suzaki
YMYusuke Mizuno
Yusuke Mizuno
NSNaotoshi Shibahara
Naotoshi Shibahara
Herbal medicine is mainly prepared from boiling herbal water extracts. Many epoch-making immunosuppressant drugs, such as glycyrrhizic acid (old example) and FTY720 (current example), were developed from herbal secondary metabolites in the boiling water extract by partition with organic solvents. However, few immunostimulants have been discovered by this method. Instead of the usual method, we aimed to find a novel immunostimulant component by two unique methods in the research of herbal medicine: ultracentrifugation and electron microscopy. The immunostimulant was not a secondary metabolite, as expected, but the structure was a nanoparticle formed by a polysaccharide. In addition, we clarified the immune effect of the nanoparticle. Intake of the nanoparticle by phagocytosis resulted in immunostimulant effects by increasing the genes and proteins of inflammatory cytokines in macrophage cells. The immunostimulant effects were inhibited by a phagocytosis inhibitor, cytochalasin D. To the best of our knowledge, this study is the first to describe the discovery of a nanoparticle in boiling herbal water extracts and its immunostimulant properties. This study will provide additional understanding of the efficacy of herbal medicine, in that the immunostimulant nanoparticle universally exists in boiling herbal water extracts. Thus, traditional herbal medicine may be an oldest known nanomedicine. Furthermore, this study suggests that the immunostimulant nanoparticle simply can be obtained from herbal medicine only by ultracentrifugation. We hope that this simple strategy will substantially contribute to drug development, including vaccine adjuvant, in the future.

24 April 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
KKKeiichi Koizumi
Keiichi Koizumi
MOMakito Oku
Makito Oku
SHShusaku Hayashi
Shusaku Hayashi
AIAkiko Inujima
Akiko Inujima
NSNaotoshi Shibahara
Naotoshi Shibahara
KAKazuyuki Aihara
Kazuyuki Aihara
In the article titled “Suppression of Dynamical Network Biomarker Signals at the Predisease State (Mibyou) before Metabolic Syndrome in Mice by a Traditional Japanese Medicine (Kampo Formula) Bofutsushosan” [1], the authors wish to clarify that the DNB scores of the untreated group shown in blue in Figure 3 were recalculated from data obtained from the Gene Expression Omnibus (GEO) repository, accession number: GSE112653 [2], and were presented for comparison. The authors confirm that this does not affect the results and conclusions of the article.

1 January 2026 in Nonlinear Theory and Its Applications, IEICE
Verified
Journal Article
Open access
PDF file
MOMakito Oku
Makito Oku
AIAkiko Inujima
Akiko Inujima
KKKeiichi Koizumi
Keiichi Koizumi
KAKazutaka Akagi
Kazutaka Akagi
SFShiho Fujisaka
Shiho Fujisaka
SSShigeru Saito
Shigeru Saito
Dynamical network biomarker (DNB) theory has emerged as a powerful framework for detecting early warning signals of pre-disease states. Based on our previous work demonstrating its utility in adipose tissue of metabolic syndrome model mice, we conducted a comprehensive DNB analysis using RNA sequencing data across 13 organs and 14 to 16 time points in high-fat diet-fed mice. Our findings revealed organ-specific variation in the timing of early warning signals, suggesting heterogeneous inter-organ dynamics during the pre-disease state of metabolic syndrome. These results highlight the potential of DNB theory for elucidating systemic early-stage pathophysiology in complex metabolic disorders.

5 February 2026 in Cells
Verified
Journal Article
Open access
PDF file
RKRyoya Kano
Ryoya Kano
COChihiro Oyama
Chihiro Oyama
CIChihiro Ikeda
Chihiro Ikeda
AIAkiko Inujima
Akiko Inujima
KKKeiichi Koizumi
Keiichi Koizumi
YHYutaka Hirose
Yutaka Hirose
PCIF1 is primarily recognized as an RNA methyltransferase that mediates N6-methylation of cap-proximal adenosine (m6Am) and plays diverse roles in gene expression. In this study, we uncover a novel role for PCIF1 as a crucial negative regulator of type I interferon (IFN) induction, a pathway critical for antiviral immunity whose dysregulation leads to inflammatory and autoimmune diseases. We demonstrate that PCIF1 deficiency robustly enhances the poly(I:C)-induced type I IFN response, accompanied by augmented STAT1 activation and interferon-stimulated gene (ISG) expression. Mechanistically, PCIF1 suppresses IFNB1 transcription by attenuating IRF3 phosphorylation and nuclear translocation, as shown by increased nascent IFNB1 mRNA synthesis and promoter activity in PCIF1-deficient cells, without affecting the mRNA stability. Crucially, this suppressive function was independent of PCIF1’s canonical RNA methyltransferase activity, as both wild-type PCIF1 and a methyltransferase-inactive mutant effectively attenuated type I IFN induction. Collectively, our findings establish PCIF1 as a novel methyltransferase-independent suppressor of type I IFN responses, revealing its previously unrecognized non-catalytic function. This discovery offers critical insights into the multifaceted regulation of innate immunity and highlights PCIF1’s non-catalytic function as a promising therapeutic target for modulating antiviral responses and inflammatory diseases.

15 June 2026 in Communications Biology
Verified
Journal Article
Open access
AIAkiko Inujima
Akiko Inujima
KKKeiichi Koizumi
Keiichi Koizumi
OAOtoya Aoyama
Otoya Aoyama
YHYutaka Hirose
Yutaka Hirose
YIYoshiya Ikawa
Yoshiya Ikawa
HSHiroaki Sakurai
Hiroaki Sakurai
According to the endosymbiotic theory, chloroplasts originate from cyanobacteria. While bacteria-derived molecules trigger immune responses via pathogen-associated molecular patterns, the immunological impact of chloroplast-derived molecules remains unclear. Here, we demonstrate that chloroplast RNA induces immune responses in mammalian cells. Using RNA sequencing analysis of total RNA extracted from Arabidopsis thaliana chloroplasts and nuclear factor-kappa B (NF-κB) reporter assays, we identify a 15-base chloroplast RNA sequence that activates NF-κB in mouse cells via Toll-like receptor (TLR)13. Additionally, a 33-base sequence containing this 15-base motif is identified that activates human cells via TLR7. This 15-base sequence is homologous to the bacterial 23S ribosomal RNA ligand for TLR13 but exhibits distinct reactivity. We also detect this 15-base sequence in the chloroplast RNA from radish, spinach, and broccoli. These findings highlight the retention of bacterial features in chloroplasts and suggest that dietary chloroplast RNA may modulate mammalian immune responses, potentially mimicking probiotic effects.